Interleukin-1 blockade with RPH-104 in patients with acute ST-elevation myocardial infarction: study design and rationale

被引:0
|
作者
M. Samsonov
V. Bogin
B. W. Van Tassell
A. Abbate
机构
[1] R-Pharm JSC,School of Pharmacy
[2] Cromos Pharma,Pauley Heart Center
[3] LLC,undefined
[4] Virginia Commonwealth University,undefined
[5] Virginia Commonwealth University,undefined
来源
Journal of Translational Medicine | / 19卷
关键词
STEMI; Myocardial infarction; Cardiovascular diseases; Inflammation; RPH-104; Trial design; IL-1;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Myocardial rupture in patients with acute ST-elevation myocardial infarction. The role of surgical treatment
    Ptaszynska-Kopczynska, Katarzyna
    Sobolewska, Dominika
    Kozuch, Marcin
    Dobrzycki, Slawomir
    Sobkowicz, Bozena
    Hirnle, Tomasz
    Musial, Wlodzimierz J.
    Kaminski, Karol A.
    KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA, 2011, 8 (02): : 262 - 267
  • [32] ST-elevation acute myocardial infarction in pregnancy: 2016 update
    Ismail, Sahar
    Wong, Cynthia
    Rajan, Priya
    Vidovich, Mladen I.
    CLINICAL CARDIOLOGY, 2017, 40 (06) : 399 - 406
  • [33] The outcome of ST-elevation myocardial infarction by sex: a retrospective cohort study
    Hassani, Neda Shafiabadi
    Mozafarybazargany, Mohammadhossein
    Pirdehghan, Reza
    Sepahvandi, Roya
    Khodaprast, Zeynab
    Karimi, Fatemeh
    Rahimi, Fatemeh
    Zakani, Akram
    Mardi, Parham
    Kamipoor, Zeinab
    Dorri, Mahya
    Bamrafie, Arya
    Rastad, Hadith
    FUTURE CARDIOLOGY, 2023, 19 (01) : 19 - 27
  • [34] Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease
    Franczyk-Skora, Beata
    Gluba, Anna
    Banach, Maciej
    Rysz, Jacek
    ARCHIVES OF MEDICAL SCIENCE, 2013, 9 (06) : 1019 - 1027
  • [35] Experimental myocardial stem cell therapy for ST-elevation myocardial infarction: rationale and level of evidence
    Kastrup, Jens
    Mygind, Naja D.
    Qayyum, Abbas A.
    Mathiasen, Anders B.
    MINERVA CARDIOANGIOLOGICA, 2016, 64 (03): : 322 - 329
  • [36] Lornoxicam for Prevention of Myocardial Injury During Acute St-Elevation Myocardial Infarction
    Parnes, E. Ia.
    Gavrilova, S. A.
    KARDIOLOGIYA, 2011, 51 (03) : 31 - 35
  • [37] Impact of the Metabolic Syndrome on the Clinical Outcome of Patients with Acute ST-Elevation Myocardial Infarction
    Lee, Min Goo
    Jeong, Myung Ho
    Ahn, Youngkeun
    Chae, Shung Chull
    Hur, Seung Ho
    Hong, Taek Jong
    Kim, Young Jo
    Seong, In Whan
    Chae, Jei Keon
    Rhew, Jay Young
    Chae, In Ho
    Cho, Myeong Chan
    Bae, Jang Ho
    Rha, Seung Woon
    Kim, Chong Jin
    Choi, Donghoon
    Jang, Yang Soo
    Yoon, Junghan
    Chung, Wook Sung
    Cho, Jeong Gwan
    Seung, Ki Bae
    Park, Seung Jung
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2010, 25 (10) : 1456 - 1461
  • [38] Predictors of Severity of Coronary Artery Disease in Patients with Acute ST-elevation Myocardial Infarction
    Karadeniz, Muhammed
    Aydin, Cihan
    Demirkiran, Aykut
    Alp, Caglar
    NAMIK KEMAL MEDICAL JOURNAL, 2024, 12 (03): : 171 - 175
  • [39] Mortality of patients with ST-elevation acute myocardial infarction treated with primary angioplasty or thrombolysis
    Greig, Douglas
    Corbalan, Ramon
    Castro, Pablo
    Campos, Pabla
    Lamich, Ruben
    Yovaniniz, Patricio
    REVISTA MEDICA DE CHILE, 2008, 136 (09) : 1098 - 1106
  • [40] Electrolyte Imbalance Among Patients With and With No ST-Elevation Myocardial Infarction A Cohort Study
    Dreidi, Mu'taz
    Asmar, Imad
    Jaghama, Maram
    Alrimawi, Intima
    Atout, Maha
    CRITICAL CARE NURSING QUARTERLY, 2023, 46 (02) : 136 - 144